04/19/2024
4:28 PM | Ocuphire Pharma, Inc. (Filer)
Ocuphire Pharma (Filer)
| Form PRE 14A | |
04/17/2024
3:23 PM | Ocuphire Pharma, Inc. (Filer)
Ocuphire Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/20/2024
3:18 PM | Magrath George (Reporting)
Ocuphire Pharma, Inc. (Issuer)
Ocuphire Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/08/2024
4:20 PM | Ocuphire Pharma, Inc. (Filer)
Ocuphire Pharma (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/08/2024
7:21 AM | Ocuphire Pharma, Inc. (Filer)
Ocuphire Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/16/2024
3:31 PM | Ocuphire Pharma, Inc. (Filer)
Ocuphire Pharma (Filer)
| Form 424B3 | |
02/14/2024
5:32 PM | Jhaveri Nirav S. (Reporting)
Ocuphire Pharma, Inc. (Issuer)
Ocuphire Pharma (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
|
02/14/2024
5:35 PM | Jayagopal Ashwath (Reporting)
Ocuphire Pharma, Inc. (Issuer)
Ocuphire Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2024
5:37 PM | Jhaveri Nirav S. (Reporting)
Ocuphire Pharma, Inc. (Issuer)
Ocuphire Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2024
5:29 PM | Jayagopal Ashwath (Reporting)
Ocuphire Pharma, Inc. (Issuer)
Ocuphire Pharma (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
01/23/2024
11:15 PM | Ocuphire Pharma, Inc. (Filer)
Ocuphire Pharma (Filer)
| Form EFFECT | |
01/22/2024
5:01 PM | Ocuphire Pharma, Inc. (Issuer)
Ocuphire Pharma (Issuer)
Zaremba Rabourn Amy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/22/2024
5:01 PM | Hoffmann Bernhard (Reporting)
Ocuphire Pharma, Inc. (Issuer)
Ocuphire Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/11/2024
3:16 PM | Ocuphire Pharma, Inc. (Filer)
Ocuphire Pharma (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
01/10/2024
4:00 PM | Ocuphire Pharma, Inc. (Filer)
Ocuphire Pharma (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
01/03/2024
4:57 PM | Benton Susan (Reporting)
Ocuphire Pharma, Inc. (Issuer)
Ocuphire Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/05/2023
3:30 PM | Ocuphire Pharma, Inc. (Issuer)
Ocuphire Pharma (Issuer)
Patel Ronil A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/27/2023
5:19 PM | Ocuphire Pharma, Inc. (Issuer)
Ocuphire Pharma (Issuer)
SCHACHLE JOSEPH K (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
11/27/2023
5:24 PM | Ocuphire Pharma, Inc. (Issuer)
Ocuphire Pharma (Issuer)
SCHACHLE JOSEPH K (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/27/2023
7:45 AM | Ocuphire Pharma, Inc. (Filer)
Ocuphire Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/13/2023
4:42 PM | Ocuphire Pharma, Inc. (Issuer)
Ocuphire Pharma (Issuer)
Rodgers Richard J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/13/2023
4:46 PM | Ocuphire Pharma, Inc. (Issuer)
Ocuphire Pharma (Issuer)
Pepose Jay (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/13/2023
7:48 AM | Ocuphire Pharma, Inc. (Filer)
Ocuphire Pharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/13/2023
7:12 AM | Ocuphire Pharma, Inc. (Filer)
Ocuphire Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/03/2023
8:22 AM | Magrath George (Reporting)
Ocuphire Pharma, Inc. (Issuer)
Ocuphire Pharma (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
11/03/2023
8:29 AM | Magrath George (Reporting)
Ocuphire Pharma, Inc. (Issuer)
Ocuphire Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/02/2023
7:44 AM | Ocuphire Pharma, Inc. (Filer)
Ocuphire Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/01/2023
3:21 PM | Ocuphire Pharma, Inc. (Filer)
Ocuphire Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/27/2023
7:45 AM | Ocuphire Pharma, Inc. (Filer)
Ocuphire Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/14/2023
7:00 AM | Ocuphire Pharma, Inc. (Filer)
Ocuphire Pharma (Filer)
| Form 424B5 | |
08/11/2023
8:27 AM | Ocuphire Pharma, Inc. (Filer)
Ocuphire Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/11/2023
7:51 AM | Ocuphire Pharma, Inc. (Filer)
Ocuphire Pharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/01/2023
10:21 AM | Ocuphire Pharma, Inc. (Filer)
Ocuphire Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/14/2023
3:31 PM | Ocuphire Pharma, Inc. (Filer)
Ocuphire Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/08/2023
5:48 PM | Gallagher Cam (Reporting)
Ocuphire Pharma, Inc. (Issuer)
Ocuphire Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/08/2023
5:48 PM | Benton Susan (Reporting)
Ocuphire Pharma, Inc. (Issuer)
Ocuphire Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/08/2023
5:49 PM | Ocuphire Pharma, Inc. (Issuer)
Ocuphire Pharma (Issuer)
Pepose Jay (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/08/2023
5:49 PM | MANUSO JAMES S J (Reporting)
Ocuphire Pharma, Inc. (Issuer)
Ocuphire Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/08/2023
5:49 PM | Ainsworth Sean (Reporting)
Ocuphire Pharma, Inc. (Issuer)
Ocuphire Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/02/2023
3:30 PM | Ocuphire Pharma, Inc. (Filer)
Ocuphire Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/15/2023
7:07 AM | Ocuphire Pharma, Inc. (Filer)
Ocuphire Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Thousands of investors use this no cost solution | Do you? (Ad) In today’s volatile markets we are all looking for the edge. But imagine tapping into a world where every investment move has the potential to be ahead of the curve.
Most investors have heard of the publication Insider Financial. For nearly a decade, they've unlocked doors to opportunities tucked away from the public eye, guiding over a million investors with well researched information before it hits the mainstream media. Simply tap here now to subscribe and start getting "Insider Financial Advantage" |
05/15/2023
7:20 AM | Ocuphire Pharma, Inc. (Filer)
Ocuphire Pharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/01/2023
3:15 PM | Ocuphire Pharma, Inc. (Filer)
Ocuphire Pharma (Filer)
| Form ARS | |
04/26/2023
8:19 PM | Ocuphire Pharma, Inc. (Issuer)
Ocuphire Pharma (Issuer)
Patel Ronil A. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
04/26/2023
8:25 PM | Ocuphire Pharma, Inc. (Issuer)
Ocuphire Pharma (Issuer)
Patel Ronil A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
